During the past decade, ASTHMA, Inc. conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 11 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ASTHMA, Inc." #1 sponsor was "DBV Technologies" with 6 trials, followed by "Sunovion" with 5 trials sponsored, "Aimmune Therapeutics, Inc." with 4 trials sponsored, "Meda Pharmaceuticals" with 4 trials sponsored and "Amphastar Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASTHMA, Inc." #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "University of Washington" with 2 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Immune Tolerance Network (ITN)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "ASTHMA, Inc." are "Peanut Allergy" (13 trials), "Asthma" (12 trials), "Perennial Allergic Rhinitis" (6 trials), "Atopic Dermatitis" (2 trials) and "Seasonal Allergic Rhinitis" (2 trials). Many other conditions were trialed in "ASTHMA, Inc." in a lesser frequency.

Most popular intervention types in "ASTHMA, Inc." are "Drug" (30 trials), "Biological" (13 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "AR101" (4 trials), "Omalizumab" (3 trials), "Viaskin Peanut 250 mcg" (3 trials) and "0.15% azelastine hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "ASTHMA, Inc." are 45 trials for "All" genders.

Currently, there are NaN active trials in "ASTHMA, Inc.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in ASTHMA, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in ASTHMA, Inc., 5 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".